Patent details

EP2969004 Title: DELAFLOXACIN FOR USE IN TREATING INFECTIONS IN OBESE PATIENTS

Basic Information

Publication number:
EP2969004
PCT Application Number:
US2014027220
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP147684567
PCT Publication Number:
WO2014152332
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
DELAFLOXACIN FOR USE IN TREATING INFECTIONS IN OBESE PATIENTS
French Title of Invention:
DELAFLOXACINE ET SON UTILISATION DANS LE TRAITEMENT D'INFECTIONS CHEZ DES PATIENTS OBÈSES
German Title of Invention:
DELAFLOXACIN ZUR VERWENDING IN DER BEHANDLUNG VON INFEKTIONEN BEI ADIPÖSEN PATIENTEN
SPC Number:

Dates

Filing date:
14/03/2014
Grant date:
25/02/2026
EP Publication Date:
20/01/2016
PCT Publication Date:
25/09/2014
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
25/02/2026
EP B1 Publication Date:
25/02/2026
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
14/03/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
18/02/2026
 
 

Name:
Melinta Subsidiary Corp.
Address:
389 Interpace Parkway Suite 450, Parsippany, NJ 07054, United States (US)

Inventor

Name:
DUFFY, Erin, M.
Address:
United States (US)

Priority

Priority Number:
201361790179 P
Priority Date:
15/03/2013
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/4709; A61P 31/04; A61K 9/00; A61K 9/20; A61P 17/00; A61K 47/40; A61K 31/133;

Publication

European Patent Bulletin

Issue number:
202609
Publication date:
25/02/2026
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
27/04/2026
Annual Fee Number:
13
Annual Fee Amount:
180 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages